Literature DB >> 11929234

Magnetic resonance imaging detects a specific peptide-protein binding event.

Luis M De León-Rodríguez1, Alfonso Ortiz, Allison L Weiner, Shanrong Zhang, Zoltan Kovacs, Thomas Kodadek, A Dean Sherry.   

Abstract

DOTA was conjugated to the N-terminus of a 12-mer peptide by using standard peptide synthesis chemistry. The peptide, first isolated by phage display, maintained a high affinity for its protein-binding target, Gal-80, even with GdDOTA attached. The high affinity constant (KA = 5 x 105 M-1) combined with the high relaxivity of the resulting GdDOTA-peptide.protein complex (r1bound = 44.8 +/- 1.7 mM-1 s-1) allowed detection of Gal-80 at muM levels using a standard magnetic resonance imaging protocol. This novel peptide-based, binding-activated MRI method could potentially be used to screen a wide variety of biomolecules.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929234     DOI: 10.1021/ja025511v

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  15 in total

1.  Toward the Design of MR Agents for Imaging β-Cell Function.

Authors:  Mark Woods; Shanrong Zhang; A Dean Sherry
Journal:  Curr Med Chem Immunol Endocr Metab Agents       Date:  2004-12

2.  The detection limit of a Gd3+-based T1 agent is substantially reduced when targeted to a protein microdomain.

Authors:  Kenjiro Hanaoka; Angelo Josue M Lubag; Aminta Castillo-Muzquiz; Thomas Kodadek; A Dean Sherry
Journal:  Magn Reson Imaging       Date:  2008-01-30       Impact factor: 2.546

Review 3.  Chemical exchange saturation transfer contrast agents for magnetic resonance imaging.

Authors:  A Dean Sherry; Mark Woods
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

Review 4.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Authors:  Aaron Joseph L Villaraza; Ambika Bumb; Martin W Brechbiel
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

5.  Effect of Peptide-Chelate Architecture on Metabolic Stability of Peptide-based MRI Contrast Agents.

Authors:  Zhaoda Zhang; Andrew F Kolodziej; Jianfeng Qi; Shrikumar A Nair; Xifang Wang; April W Case; Matthew T Greenfield; Philip B Graham; Thomas J McMurry; Peter Caravan
Journal:  New J Chem       Date:  2010-02-12       Impact factor: 3.591

6.  Comparison of the equilibrium, kinetic and water exchange properties of some metal ion-DOTA and DOTA-bis(amide) complexes.

Authors:  Gyula Tircsó; Enikő Tircsóné Benyó; Zoltán Garda; Jaspal Singh; Robert Trokowski; Ernő Brücher; A Dean Sherry; Éva Tóth; Zoltán Kovács
Journal:  J Inorg Biochem       Date:  2020-02-20       Impact factor: 4.155

7.  A smart T(1)-weighted MRI contrast agent for uranyl cations based on a DNAzyme-gadolinium conjugate.

Authors:  Weichen Xu; Hang Xing; Yi Lu
Journal:  Analyst       Date:  2013-11-07       Impact factor: 4.616

Review 8.  Environmentally responsive MRI contrast agents.

Authors:  Gemma-Louise Davies; Iris Kramberger; Jason J Davis
Journal:  Chem Commun (Camb)       Date:  2013-10-28       Impact factor: 6.222

9.  Characterization of estrogen-receptor-targeted contrast agents in solution, breast cancer cells, and tumors in vivo.

Authors:  Adi Pais; Inbal Eti Biton; Raanan Margalit; Hadassa Degani
Journal:  Magn Reson Med       Date:  2012-08-10       Impact factor: 4.668

10.  A new gadolinium-based MRI zinc sensor.

Authors:  Ana C Esqueda; Jorge A López; Gabriel Andreu-de-Riquer; José C Alvarado-Monzón; James Ratnakar; Angelo J M Lubag; A Dean Sherry; Luis M De León-Rodríguez
Journal:  J Am Chem Soc       Date:  2009-08-19       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.